NCT05630170View on ClinicalTrials.gov

The SMART-LV Pilot Study

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 13, 2023

Primary Completion Date

May 21, 2024

Study Completion Date

May 22, 2024

Conditions
Left Ventricular Systolic Dysfunction
Interventions
DEVICE

AI-ECG

A novel AI-ECG model developed at the Cardiovascular Data Science (CarDS) lab will be used as Software as Medical Device (SaMD) on ECG images for detection of LVSD.

Trial Locations (1)

06520

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT05630170 - The SMART-LV Pilot Study | Biotech Hunter | Biotech Hunter